共 356 条
[1]
la Fougère C(2011)Molecular imaging of gliomas with PET: opportunities and limitations Neuro Oncol 13 806-819
[2]
Suchorska B(2014)GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity Neuro Oncol 16 1167-1175
[3]
Bartenstein P(2015)Radiogenomics: what it is and why it is important J Am Coll Radiol 12 862-866
[4]
Kreth FW(2020)The additional value of (18)F-FDG PET and MRI in patients with glioma: a review of the literature from 2015 to 2020 Diagnostics (Basel, Switzerland) 10 357-149
[5]
Tonn JC(2017)Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective Clin Transl Imaging 5 135-1295
[6]
Vartanian A(2016)Simultaneous 11C-methionine positron emission tomography/magnetic resonance imaging of suspected primary brain tumors PLOS ONE 11 1285-656
[7]
Singh SK(2017)Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI: a feasibility study Eur J Nucl Med Mol Imaging 44 650-422
[8]
Agnihotri S(2019)Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in the evaluation of glioma J Med Imaging Radiat Oncol 63 412-601
[9]
Jalali S(2020)Improved detection of diffuse glioma infiltration with imaging combinations: a diagnostic accuracy study Neuro Oncol 22 593-559
[10]
Burrell K(2018)(11)C-MET PET/MRI for detection of recurrent glioma Eur J Nucl Med Mol Imaging 45 550-389